Cargando…

Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer

Detalles Bibliográficos
Autores principales: Sturrock, M., Miller, I. S., Kang, G., Arba’ie, N. Hannis, O’Farrell, A. C., Barat, A., Marston, G., Coletta, P. L., Byrne, A. T., Prehn, J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160440/
https://www.ncbi.nlm.nih.gov/pubmed/30262882
http://dx.doi.org/10.1038/s41598-018-31456-9
_version_ 1783358765582516224
author Sturrock, M.
Miller, I. S.
Kang, G.
Arba’ie, N. Hannis
O’Farrell, A. C.
Barat, A.
Marston, G.
Coletta, P. L.
Byrne, A. T.
Prehn, J. H.
author_facet Sturrock, M.
Miller, I. S.
Kang, G.
Arba’ie, N. Hannis
O’Farrell, A. C.
Barat, A.
Marston, G.
Coletta, P. L.
Byrne, A. T.
Prehn, J. H.
author_sort Sturrock, M.
collection PubMed
description
format Online
Article
Text
id pubmed-6160440
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61604402018-09-28 Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer Sturrock, M. Miller, I. S. Kang, G. Arba’ie, N. Hannis O’Farrell, A. C. Barat, A. Marston, G. Coletta, P. L. Byrne, A. T. Prehn, J. H. Sci Rep Author Correction Nature Publishing Group UK 2018-09-27 /pmc/articles/PMC6160440/ /pubmed/30262882 http://dx.doi.org/10.1038/s41598-018-31456-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Sturrock, M.
Miller, I. S.
Kang, G.
Arba’ie, N. Hannis
O’Farrell, A. C.
Barat, A.
Marston, G.
Coletta, P. L.
Byrne, A. T.
Prehn, J. H.
Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
title Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
title_full Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
title_fullStr Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
title_full_unstemmed Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
title_short Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
title_sort author correction: anti-angiogenic drug scheduling optimisation with application to colorectal cancer
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160440/
https://www.ncbi.nlm.nih.gov/pubmed/30262882
http://dx.doi.org/10.1038/s41598-018-31456-9
work_keys_str_mv AT sturrockm authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT milleris authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT kangg authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT arbaienhannis authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT ofarrellac authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT barata authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT marstong authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT colettapl authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT byrneat authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer
AT prehnjh authorcorrectionantiangiogenicdrugschedulingoptimisationwithapplicationtocolorectalcancer